Monitoring of PDCA quality improvement process for drug adverse reaction management
10.3760/cma.j.issn.1000-6672.2011.04.017
- VernacularTitle:PDCA管理在药物不良反应监测中的应用
- Author:
Guoguang ZHAO
;
Xin WANG
;
Yongzhong LI
;
Yuqin WANG
;
Lihong WANG
- Publication Type:Journal Article
- Keywords:
Drug adverse reaction;
PDCA eycle;
Proactive reporting system;
Quality of care management
- From:
Chinese Journal of Hospital Administration
2011;27(4):297-300
- CountryChina
- Language:Chinese
-
Abstract:
Objective Patient safety is key to quality of care in hospital management, for which drug safety is critical. General hospitals are challenged with how to monitor drug adverse reaction (ADR), and motivate their staff to report ADRs in building a hospital safety culture. Methods The PDCA cycle quality improvement process was called into play, to set the ADR criteria and analyze data of inpatients' ADRs from 2005 to 2009, which was followed by measures proposed for ADR continuous improvement. Results A total of 2850 ADR cases were reported in the past 5 years, averaging 570 cases per year. The ADR incidence rate was 3. 28%, of which 43 were severe ADR cases, or 0. 49% of the total cases, accounting for 1. 51% of all the ADR cases. Year to year, the quantity and quality of ADR reporting have been improving in the hospital, witnessing an initial culture of drug safety. In 2008, the hospital was awarded as an advanced ADR center in Beijing. Conclusion The PDCA cycle is an effective means for ADR management, as it can improve the awareness of the medical staff for proactive ADR reporting. Sustained circular management against ADRs can minimize risks and maximize patient safety.Under-reporting and the corrective measures shall be watched over by the hospital in the future.
